Approval · Notice of Compliance 20620 · 2018
BESPONSA: Notice of Compliance 20620
Issued March 15, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20620
- Date
- March 15, 2018
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BESPONSA | Not yet assigned | — |
Medicinal ingredients
- INOTUZUMAB OZOGAMICIN 0.9 MG per VIAL